Guest guest Posted December 21, 2004 Report Share Posted December 21, 2004 Genmab, Medarex say autoimmune drug data "encouraging CBS MarketWatch - USA .... Tuesday "encouraging safety and efficacy" data from a Phase I/II trial using HuMax- Inflam/MDX-018 to treat patients suffering from an autoimmune disease. ... http://cbs.marketwatch.com/news/newsfinder/pulseone.asp?guid=%7BD22FA084-E54D-49BB-8BCA-90B1444C624B%7D & siteid=google & dist=google Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.